Ivermectin: Difference between revisions
(Restore original dosing content alongside dynamic SMW tables) |
(Remove disease-specific dosing covered by dynamic SMW tables) |
||
| Line 10: | Line 10: | ||
===[[Onchocerciasis]]=== | ===[[Onchocerciasis]]=== | ||
*0.15mg/kg PO x1 | *0.15mg/kg PO x1 | ||
===[[Pediculosis capitis]]=== | ===[[Pediculosis capitis]]=== | ||
Revision as of 02:58, 20 March 2026
General
- Type: antiparasitic
- Dosage Forms: Tablet, 3mg
- Common Trade Names: Stromectol
Adult Dosing
Strongyloidiasis
- 0.2mg/kg PO x1
Onchocerciasis
- 0.15mg/kg PO x1
Pediculosis capitis
- 0.2mg/kg pO q10 days x2 doses
Pediculosis corporis
- 12mg PO q7 days x3 doses
Pediculosis pubis
- 0.25mg/kg PO q2wk x2 doses
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Onchocerciasis | 0.15mg/kg PO x1 | Onchocerciasis |
| Scabies | 200mcg/kg PO repeat in 2wks | Severe infection |
| Strongyloides stercoralis | 0.2mg/kg PO x1 | Strongyloidiasis |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Scabies | 200mcg/kg PO, repeat in 2 weeks; only for children >15kg | Pediatric Severe (>15kg) |
Special Populations
- Pregnancy Rating: C
- Lactation: Safety Unknown
- Renal Dosing- not defined
- Hepatic Dosing- not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- hypotension, orthostatic
- tachycardia
- seizures
- Stevens-Johnson syndrome
- toxic epidermal necrolysis
- asthma exacerbation
- vision loss
- conjunctival hemorrhage
- hepatitis
Common
- pruritus
- rash
- fever
- edema
- lymphadenopathy
- headache
- myalgia
- dizziness
- tachycardia
- abnormal eye sensation
- limbitis
- conjunctivitis
- ocular inflammation
- hypotension, orthostatic
- ALT, AST elevated
- eosinophilia
Pharmacology
- Half-life: 18h
- Metabolism: liver, CYP450: unknown
- Excretion: feces primarily, urine < 1%
- Mechanism of Action: increases invertebrate nerve and muscle cell membrane permeability by binding to chloride ion channels, resulting in paralysis and death of parasite
